183 related articles for article (PubMed ID: 8577268)
21. Earlier detection of human immunodeficiency virus type 1 p24 antigen and immunoglobulin G and M antibodies to p17 antigen in seroconversion serum panels by immune complex transfer enzyme immunoassays.
Hashida S; Ishikawa S; Hashinaka K; Nishikata I; Oka S; Ishikawa E
Clin Diagn Lab Immunol; 2000 Nov; 7(6):872-81. PubMed ID: 11063490
[TBL] [Abstract][Full Text] [Related]
22. Preclinical studies on immunogenicity of the HIV-1 p17-based synthetic peptide AT20-KLH.
Fiorentini S; Marini E; Bozzo L; Trainini L; Saadoune L; Avolio M; Pontillo A; Bonfanti C; Sarmientos P; Caruso A
Biopolymers; 2004; 76(4):334-43. PubMed ID: 15386266
[TBL] [Abstract][Full Text] [Related]
23. Use of indirectly immobilized recombinant p17 antigen for detection of antibodies to HIV-1 by enzyme immunoassay.
Ishikawa S; Hashinaka K; Hashida S; Oka S; Ishikawa E
J Clin Lab Anal; 1999; 13(1):9-18. PubMed ID: 10025732
[TBL] [Abstract][Full Text] [Related]
24. Immunologic cross-reaction between HIV type 1 p17 and Mycoplasma hyorhinis variable lipoprotein.
Pincus SH; Cole RL; Watson-McKown R; Pinter A; Honnen W; Cole B; Wise KS
AIDS Res Hum Retroviruses; 1998 Mar; 14(5):419-25. PubMed ID: 9546801
[TBL] [Abstract][Full Text] [Related]
25. A neutralizing monoclonal antibody previously mapped exclusively on human immunodeficiency virus type 1 gp41 recognizes an epitope in p17 sharing the core sequence IEEE.
Buratti E; Tisminetzky SG; D'Agaro P; Baralle FE
J Virol; 1997 Mar; 71(3):2457-62. PubMed ID: 9032383
[TBL] [Abstract][Full Text] [Related]
26. Clonal analysis of murine B cell response to the human immunodeficiency virus type 1 (HIV1)-gag p17 and p25 antigens.
Robert-Hebmann V; Emiliani S; Jean F; Resnicoff M; Traincard F; Devaux C
Mol Immunol; 1992 Jun; 29(6):729-38. PubMed ID: 1376412
[TBL] [Abstract][Full Text] [Related]
27. Differential maturation of avidity of IgG antibodies to gp41, p24 and p17 following infection with HIV-1.
Thomas HI; Wilson S; O'Toole CM; Lister CM; Saeed AM; Watkins RP; Morgan-Capner P
Clin Exp Immunol; 1996 Feb; 103(2):185-91. PubMed ID: 8565298
[TBL] [Abstract][Full Text] [Related]
28. Gag-derived proteins of HIV-1 isolates from Indian patients: cloning, expression, and purification of p17 of B- and C-subtypes.
Gupta S; Arora K; Gupta A; Chaudhary VK
Protein Expr Purif; 2001 Apr; 21(3):378-85. PubMed ID: 11281711
[TBL] [Abstract][Full Text] [Related]
29. More reliable diagnosis of infection with human immunodeficiency virus type 1 (HIV-1) by detection of antibody IgGs to pol and gag proteins of HIV-1 and p24 antigen of HIV-1 in urine, saliva, and/or serum with highly sensitive and specific enzyme immunoassay (immune complex transfer enzyme immunoassay): a review.
Hashida S; Hashinaka K; Ishikawa S; Ishikawa E
J Clin Lab Anal; 1997; 11(5):267-86. PubMed ID: 9292394
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory mechanism of anti-P30-52 monoclonal antibody against human immunodeficiency virus type 1 (HIV-1) multiplication in infected MT-4 cells.
Ota A; Ueda S
Hybridoma; 1999 Jun; 18(3):235-41. PubMed ID: 10475237
[TBL] [Abstract][Full Text] [Related]
31. Epitope mapping of the HIV-1 gag region with monoclonal antibodies.
Hinkula J; Rosen J; Sundqvist VA; Stigbrand T; Wahren B
Mol Immunol; 1990 May; 27(5):395-403. PubMed ID: 1694957
[TBL] [Abstract][Full Text] [Related]
32. Specific antibody responses to synthetic peptides of HIV-1 p17 correlate with different stages of HIV-1 infection.
Jiang JD; Chu FN; Naylor PH; Kirkley JE; Mandeli J; Wallace JI; Sarin PS; Goldstein AL; Holland JF; Bekesi JG
J Acquir Immune Defic Syndr (1988); 1992; 5(4):382-90. PubMed ID: 1372353
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and persistence of antibody titers to recombinant HIV-1 core and matrix proteins in HIV-1 infection.
Janvier B; Mallet F; Cheynet V; Dalbon P; Vernet G; Besnier JM; Choutet P; Goudeau A; Mandrand B; Barin F
J Acquir Immune Defic Syndr (1988); 1993 Aug; 6(8):898-903. PubMed ID: 8315575
[TBL] [Abstract][Full Text] [Related]
34. Cross-clade p17 peptide recognition by antisera to HGP-30, a 30-amino acid synthetic peptide antigen from HIV type 1 p17.
Zimmerman DH; Ulrich JT; Wright C; Lloyd JP; Winship MD; Sarin PS
AIDS Res Hum Retroviruses; 1998 Jun; 14(9):741-9. PubMed ID: 9643374
[TBL] [Abstract][Full Text] [Related]
35. HIV Gag p17 protein impairs proliferation of normal lymphocytes in vitro.
Hofmann B; Nishanian P; Fan J; Nguyen T; Fahey JL
AIDS; 1994 Jul; 8(7):1016-7. PubMed ID: 7946090
[No Abstract] [Full Text] [Related]
36. Immunodominant epitopes of HIV-1 p17 and p24.
Graham S; Follett EA; Wallace L; Desselberger U; Marsden HS
AIDS Res Hum Retroviruses; 1992 Oct; 8(10):1781-8. PubMed ID: 1280955
[TBL] [Abstract][Full Text] [Related]
37. [Anti-HIV-1 p17 antibody as anti-HIV agent].
Tsuchie H; Tochikura A; Kageyama S; Kurimura T
Nihon Rinsho; 1993 Sep; 51 Suppl():213-8. PubMed ID: 8271386
[No Abstract] [Full Text] [Related]
38. Prevalence of antibodies to the core protein P17, a serological marker during HIV-1 infection.
Mehta SU; Rupprecht KR; Hunt JC; Kramer DE; McRae BJ; Allen RG; Dawson GJ; Devare SG
AIDS Res Hum Retroviruses; 1990 Apr; 6(4):443-54. PubMed ID: 1692727
[TBL] [Abstract][Full Text] [Related]
39. Human immunodeficiency virus type 1-neutralizing monoclonal antibodies which react with p17 core protein: characterization and epitope mapping.
Papsidero LD; Sheu M; Ruscetti FW
J Virol; 1989 Jan; 63(1):267-72. PubMed ID: 2462060
[TBL] [Abstract][Full Text] [Related]
40. A longitudinal study of the IgG antibody response to HIV-1 p17 gag protein in HIV-1+ patients with haemophilia: titre and avidity.
Chargelegue D; O'Toole CM; Colvin BT
Clin Exp Immunol; 1993 Sep; 93(3):331-6. PubMed ID: 8370162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
